[Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens]

Orv Hetil. 2013 Apr 21;154(16):627-32. doi: 10.1556/OH.2013.29590.
[Article in Hungarian]

Abstract

Background: Grade 2 breast carcinomas do not form a uniform prognostic group.

Aim: To extend the number of patients and the investigated genes of a previously identified prognostic signature described by the authors that reflect chromosomal instability in order to refine characterization of grade 2 breast cancers and identify driver genes.

Methods: Using publicly available databases, the authors selected 9 target and 3 housekeeping genes that are capable to divide grade 2 breast carcinomas into prognostic groups. Gene expression was investigated by polymerase chain reaction in 249 formalin-fixed, paraffin-embedded breast tumors. The results were correlated with relapse-free survival.

Results: Histologically grade 2 carcinomas were split into good and a poor prognosis groups. Centroid-based ranking showed that 3 genes, FOXM1, TOP2A and CLDN4 were able to separate the good and poor prognostic groups of grade 2 breast carcinomas.

Conclusion: Using appropriately selected control genes, a limited set of genes is able to split prognostic groups of breast carcinomas independently from their grade.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Computer Simulation
  • Disease-Free Survival
  • Female
  • Fixatives
  • Formaldehyde
  • Gene Expression Profiling / economics
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation, Neoplastic
  • Health Care Costs
  • Humans
  • Middle Aged
  • Neoplasm Grading
  • Paraffin Embedding
  • Polymerase Chain Reaction / methods
  • Predictive Value of Tests
  • Prognosis
  • Treatment Outcome

Substances

  • Fixatives
  • Formaldehyde